Nor Ursodeoxycholic Acid

去甲熊去氧胆酸

Report date: 2026/02/04 16:37:14
NME

Base Information

Drug NameNor Ursodeoxycholic Acid
Drug Alias NameNorUDCAUrsodeoxycholic acid homologuenorucholic acidNUC(Dr. Falk Pharma)Norursodeoxycholic acid +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionCholesterol inhibitors
TargetsCholesterol
Therapy Area/IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, Sclerosing
Global Approved IndicationsMetabolic Dysfunction-Associated Steatotic Liver Disease
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2025/08/14
Country/TerritoryNorwayAustriaGermany +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDr. Falk Pharma GmbH
China Registration ClassN/A

Develop Information

Active CompaniesDr Falk Pharma GmbHShilpa Medicare Ltd
Inactive CompaniesN/A
Active IndicationsMetabolic Dysfunction-Associated Steatotic Liver DiseaseCholangitis, Sclerosing
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBank